{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:41:04Z","timestamp":1791823264819,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,6,20]],"date-time":"2010-06-20T00:00:00Z","timestamp":1276992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1038\/nm.2171","type":"journal-article","created":{"date-parts":[[2010,6,20]],"date-time":"2010-06-20T20:18:42Z","timestamp":1277065122000},"page":"788-792","source":"Crossref","is-referenced-by-count":163,"title":["Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models"],"prefix":"10.1038","volume":"16","author":[{"given":"Thomas A","family":"Natoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie A","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Komarnitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeva","family":"Budman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Belenky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay O","family":"Bukanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R","family":"Dackowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Husson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Shayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R","family":"Ledbetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oxana","family":"Ibraghimov-Beskrovnaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,20]]},"reference":[{"key":"BFnm2171_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/ki.2009.128","volume":"76","author":"VE Torres","year":"2009","unstructured":"Torres, V.E. & Harris, P.C. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int. 76, 149\u2013168 (2009).","journal-title":"Kidney Int."},{"key":"BFnm2171_CR2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature05348","volume":"444","author":"NO Bukanov","year":"2006","unstructured":"Bukanov, N.O., Smith, L.A., Klinger, K.W., Ledbetter, S.R. & Ibraghimov-Beskrovnaya, O. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature 444, 949\u2013952 (2006).","journal-title":"Nature"},{"key":"BFnm2171_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1681\/ASN.2004080660","volume":"16","author":"Y Tao","year":"2005","unstructured":"Tao, Y., Kim, J., Schrier, R.W. & Edelstein, C.L. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J. Am. Soc. Nephrol. 16, 46\u201351 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnm2171_CR4","doi-asserted-by":"crossref","unstructured":"Leuenroth, S.J., Bencivenga, N., Chahboune, H., Hyder, F. & Crews, C.M. Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD. Nephrol. Dial Transplant. published online, doi:10.1093\/ndt\/gfp777 (4 February 2010).","DOI":"10.1093\/ndt\/gfp777"},{"key":"BFnm2171_CR5","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/nm935","volume":"9","author":"VH Gattone II","year":"2003","unstructured":"Gattone, V.H. II, Wang, X., Harris, P.C. & Torres, V.E. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat. Med. 9, 1323\u20131326 (2003).","journal-title":"Nat. Med."},{"key":"BFnm2171_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1523-1755.2005.00395.x","volume":"68","author":"P Ruggenenti","year":"2005","unstructured":"Ruggenenti, P. et al. Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int. 68, 206\u2013216 (2005).","journal-title":"Kidney Int."},{"key":"BFnm2171_CR7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/ndt\/gfi181","volume":"21","author":"PR Wahl","year":"2006","unstructured":"Wahl, P.R. et al. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). Nephrol. Dial. Transplant. 21, 598\u2013604 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnm2171_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1681\/ASN.2009040421","volume":"21","author":"JM Shillingford","year":"2010","unstructured":"Shillingford, J.M., Piontek, K.B., Germino, G.G. & Weimbs, T. Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1. J. Am. Soc. Nephrol. 21, 489\u2013497 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnm2171_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1023\/B:GLYC.0000046274.35732.47","volume":"21","author":"E Bieberich","year":"2004","unstructured":"Bieberich, E. Integration of glycosphingolipid metabolism and cell-fate decisions in cancer and stem cells: review and hypothesis. Glycoconj. J. 21, 315\u2013327 (2004).","journal-title":"Glycoconj. J."},{"key":"BFnm2171_CR10","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1056\/NEJM199307293290508","volume":"329","author":"PA Gabow","year":"1993","unstructured":"Gabow, P.A. Autosomal dominant polycystic kidney disease. N. Engl. J. Med. 329, 332\u2013342 (1993).","journal-title":"N. Engl. J. Med."},{"key":"BFnm2171_CR11","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1097\/01.ASN.0000028643.17901.42","volume":"13","author":"P Igarashi","year":"2002","unstructured":"Igarashi, P. & Somlo, S. Genetics and pathogenesis of polycystic kidney disease. J. Am. Soc. Nephrol. 13, 2384\u20132398 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnm2171_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1681\/ASN.2008050456","volume":"20","author":"F Hildebrandt","year":"2009","unstructured":"Hildebrandt, F., Attanasio, M. & Otto, E. Nephronophthisis: disease mechanisms of a ciliopathy. J. Am. Soc. Nephrol. 20, 23\u201335 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnm2171_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1083\/jcb.200503053","volume":"169","author":"LM Quarmby","year":"2005","unstructured":"Quarmby, L.M. & Parker, J.D. Cilia and the cell cycle? J. Cell Biol. 169, 707\u2013710 (2005).","journal-title":"J. Cell Biol."},{"key":"BFnm2171_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/ng1552","volume":"37","author":"M Simons","year":"2005","unstructured":"Simons, M. et al. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat. Genet. 37, 537\u2013543 (2005).","journal-title":"Nat. Genet."},{"key":"BFnm2171_CR15","doi-asserted-by":"publisher","first-page":"40419","DOI":"10.1074\/jbc.M405079200","volume":"279","author":"T Yamaguchi","year":"2004","unstructured":"Yamaguchi, T. et al. Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J. Biol. Chem. 279, 40419\u201340430 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnm2171_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1440-1797.2007.00811.x","volume":"12","author":"PR Wahl","year":"2007","unstructured":"Wahl, P.R. et al. Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease. Nephrology (Carlton) 12, 357\u2013363 (2007).","journal-title":"Nephrology (Carlton)"},{"key":"BFnm2171_CR17","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.2165\/00003495-200767170-00004","volume":"67","author":"A Masoumi","year":"2007","unstructured":"Masoumi, A., Reed-Gitomer, B., Kelleher, C. & Schrier, R.W. Potential pharmacological interventions in polycystic kidney disease. Drugs 67, 2495\u20132510 (2007).","journal-title":"Drugs"},{"key":"BFnm2171_CR18","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1007\/s00018-007-7076-0","volume":"64","author":"S Lahiri","year":"2007","unstructured":"Lahiri, S. & Futerman, A.H. The metabolism and function of sphingolipids and glycosphingolipids. Cell. Mol. Life Sci. 64, 2270\u20132284 (2007).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnm2171_CR19","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0022-2275(20)39163-X","volume":"37","author":"S Chatterjee","year":"1996","unstructured":"Chatterjee, S., Shi, W.Y., Wilson, P. & Mazumdar, A. Role of lactosylceramide and MAP kinase in the proliferation of proximal tubular cells in human polycystic kidney disease. J. Lipid Res. 37, 1334\u20131344 (1996).","journal-title":"J. Lipid Res."},{"key":"BFnm2171_CR20","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1074\/jbc.270.6.2859","volume":"270","author":"CS Rani","year":"1995","unstructured":"Rani, C.S. et al. Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclin-dependent kinases. J. Biol. Chem. 270, 2859\u20132867 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnm2171_CR21","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/381800a0","volume":"381","author":"O Cuvillier","year":"1996","unstructured":"Cuvillier, O. et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381, 800\u2013803 (1996).","journal-title":"Nature"},{"key":"BFnm2171_CR22","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/sj.cdd.4401405","volume":"11","author":"S Hong","year":"2004","unstructured":"Hong, S., Huo, H., Xu, J. & Liao, K. Insulin-like growth factor-1 receptor signaling in 3T3\u2013L1 adipocyte differentiation requires lipid rafts but not caveolae. Cell Death Differ. 11, 714\u2013723 (2004).","journal-title":"Cell Death Differ."},{"key":"BFnm2171_CR23","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1073\/pnas.0635898100","volume":"100","author":"T Yamashita","year":"2003","unstructured":"Yamashita, T. et al. Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc. Natl. Acad. Sci. USA 100, 3445\u20133449 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2171_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/glycob\/6.4.399","volume":"6","author":"A Rebbaa","year":"1996","unstructured":"Rebbaa, A., Hurh, J., Yamamoto, H., Kersey, D.S. & Bremer, E.G. Ganglioside GM3 inhibition of EGF receptor mediated signal transduction. Glycobiology 6, 399\u2013406 (1996).","journal-title":"Glycobiology"},{"key":"BFnm2171_CR25","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1074\/jbc.M103705200","volume":"277","author":"S Tagami","year":"2002","unstructured":"Tagami, S. et al. Ganglioside GM3 participates in the pathological conditions of insulin resistance. J. Biol. Chem. 277, 3085\u20133092 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm2171_CR26","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0022-2275(20)41159-9","volume":"35","author":"GD Deshmukh","year":"1994","unstructured":"Deshmukh, G.D., Radin, N.S., Gattone, V.H. II & Shayman, J.A. Abnormalities of glycosphingolipid, sulfatide and ceramide in the polycystic (cpk\/cpk) mouse. J. Lipid Res. 35, 1611\u20131618 (1994).","journal-title":"J. Lipid Res."},{"key":"BFnm2171_CR27","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.febslet.2007.03.065","volume":"581","author":"P Janich","year":"2007","unstructured":"Janich, P. & Corbeil, D. GM1 and GM3 gangliosides highlight distinct lipid microdomains within the apical domain of epithelial cells. FEBS Lett. 581, 1783\u20131787 (2007).","journal-title":"FEBS Lett."},{"key":"BFnm2171_CR28","doi-asserted-by":"publisher","first-page":"14662","DOI":"10.1074\/jbc.274.21.14662","volume":"274","author":"L Lee","year":"1999","unstructured":"Lee, L., Abe, A. & Shayman, J.A. Improved inhibitors of glucosylceramide synthase. J. Biol. Chem. 274, 14662\u201314669 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnm2171_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/oxfordjournals.jbchem.a123736","volume":"111","author":"A Abe","year":"1992","unstructured":"Abe, A. et al. Improved inhibitors of glucosylceramide synthase. J. Biochem. 111, 191\u2013196 (1992).","journal-title":"J. Biochem."},{"key":"BFnm2171_CR30","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2337\/db06-0719","volume":"56","author":"H Zhao","year":"2007","unstructured":"Zhao, H. et al. Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes. Diabetes 56, 1210\u20131218 (2007).","journal-title":"Diabetes"},{"key":"BFnm2171_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ymgme.2007.04.001","volume":"91","author":"KA McEachern","year":"2007","unstructured":"McEachern, K.A. et al. A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease. Mol. Genet. Metab. 91, 259\u2013267 (2007).","journal-title":"Mol. Genet. Metab."},{"key":"BFnm2171_CR32","doi-asserted-by":"crossref","unstructured":"Lukina, E. et al. A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1. Blood published online, doi:10.1182\/blood-2010-03-273151 (3 May 2010).","DOI":"10.1182\/blood-2010-03-273151"},{"key":"BFnm2171_CR33","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1681\/ASN.2006020136","volume":"17","author":"LA Smith","year":"2006","unstructured":"Smith, L.A. et al. Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities and common features with human disease. J. Am. Soc. Nephrol. 17, 2821\u20132831 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnm2171_CR34","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1681\/ASN.V17980","volume":"1","author":"H Takahashi","year":"1991","unstructured":"Takahashi, H. et al. A hereditary model of slowly progressive polycystic kidney disease in the mouse. J. Am. Soc. Nephrol. 1, 980\u2013989 (1991).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnm2171_CR35","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1681\/ASN.2007040490","volume":"19","author":"EA Otto","year":"2008","unstructured":"Otto, E.A. et al. NEK8 mutations affect ciliary and centrosomal localization and may cause nephronophthisis. J. Am. Soc. Nephrol. 19, 587\u2013592 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnm2171_CR36","doi-asserted-by":"publisher","first-page":"F73","DOI":"10.1152\/ajprenal.00362.2007","volume":"294","author":"TA Natoli","year":"2008","unstructured":"Natoli, T.A. et al. Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures. Am. J. Physiol. Renal Physiol. 294, F73\u2013F83 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnm2171_CR37","doi-asserted-by":"crossref","first-page":"22968","DOI":"10.1016\/S0021-9258(18)54449-5","volume":"266","author":"JA Shayman","year":"1991","unstructured":"Shayman, J.A. et al. Modulation of renal epithelial cell growth by glucosylceramide. Association with protein kinase C, sphingosine, and diacylglycerol. J. Biol. Chem. 266, 22968\u201322974 (1991).","journal-title":"J. Biol. Chem."},{"key":"BFnm2171_CR38","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1093\/nar\/gng012","volume":"31","author":"J Seibler","year":"2003","unstructured":"Seibler, J. et al. Rapid generation of inducible mouse mutants. Nucleic Acids Res. 31, e12 (2003).","journal-title":"Nucleic Acids Res."},{"key":"BFnm2171_CR39","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch, J., Lees, M. & Sloane Stanley, G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497\u2013509 (1957).","journal-title":"J. Biol. Chem."},{"key":"BFnm2171_CR40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0026-265X(01)00097-2","volume":"70","author":"K Jankowski","year":"2001","unstructured":"Jankowski, K. Microdetermination of phosphorus in organic materials from polymer industry by microwave-induced plasma atomic emission spectrometry after microwave digestion. Microchem. J. 70, 41\u201349 (2001).","journal-title":"Microchem. J."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.2171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2171","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:25:43Z","timestamp":1684434343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.2171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,20]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["BFnm2171"],"URL":"https:\/\/doi.org\/10.1038\/nm.2171","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.4076956.4458054","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.4076956.3849054","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,20]]}}}